O'Brien W F, Krammer J, O'Leary T D, Mastrogiannis D S
Department of Obstetrics and Gynecology, University of South Florida College of Medicine, Tampa 33606.
Am J Obstet Gynecol. 1993 Apr;168(4):1164-9. doi: 10.1016/0002-9378(93)90362-m.
The purpose of this study was to determine if acetaminophen decreased prostacyclin production by endothelial cells in culture and by pregnant women.
The effect of acetaminophen on endothelial cells in culture was determined by the addition of acetaminophen in concentrations of 10 and 100 micrograms/ml with comparison to control and indomethacin at 10 micrograms/ml. Prostacyclin production was estimated in 24 and thromboxane A2 production in six third-trimester pregnant women by measurement of excretion of urinary metabolites before and after ingestion of either 1000 mg of acetaminophen or placebo.
Compared with control (549 +/- 61 pg/well, mean +/- SD), production of prostacyclin in vitro was significantly inhibited by acetaminophen at 10 micrograms/ml (321 +/- 25) and 100 micrograms/ml (257 +/- 14). This inhibition is similar to inhibition by 10 micrograms/ml of indomethacin (228 +/- 11). Excretion of prostacyclin metabolite was significantly lower after ingestion of acetaminophen (2233 +/- 446 vs 1246 +/- 199 pg/mg creatinine, mean +/- SEM) but unchanged after ingestion of placebo (1745 +/- 304 vs 1712 +/- 211). There was no difference in response between normal and hypertensive women, and there was no effect of acetaminophen on thromboxane metabolite excretion.
Acetaminophen in typical oral doses results in reduced production of prostacyclin by endothelial cells in culture and in a reduction in prostacyclin, but not thromboxane, production in pregnant women.
本研究旨在确定对乙酰氨基酚是否会降低培养的内皮细胞以及孕妇体内前列环素的生成。
通过添加浓度为10微克/毫升和100微克/毫升的对乙酰氨基酚,并与浓度为10微克/毫升的对照组和吲哚美辛进行比较,来确定对乙酰氨基酚对培养的内皮细胞的影响。通过测量1000毫克对乙酰氨基酚或安慰剂摄入前后尿代谢产物的排泄情况,估计24名孕晚期孕妇体内前列环素的生成以及6名孕晚期孕妇体内血栓素A2的生成。
与对照组(549±61皮克/孔,平均值±标准差)相比,浓度为10微克/毫升(321±25)和100微克/毫升(257±14)的对乙酰氨基酚显著抑制了体外前列环素的生成。这种抑制作用与10微克/毫升吲哚美辛(228±11)的抑制作用相似。摄入对乙酰氨基酚后,前列环素代谢产物的排泄显著降低(2233±446对1246±199皮克/毫克肌酐,平均值±标准误),但摄入安慰剂后无变化(1745±304对1712±211)。正常孕妇和高血压孕妇的反应无差异,对乙酰氨基酚对血栓素代谢产物排泄无影响。
典型口服剂量的对乙酰氨基酚会导致培养的内皮细胞中前列环素生成减少,且孕妇体内前列环素生成减少,但对血栓素生成无影响。